chain reaction (PCR), single-strand conformational polymorphism (SSCP) and DNA sequencing analysis techniques were used to detect variant in the exon 10 of ␣-adducin gene. The urine and blood sample were collected for measurements of the urinary Na ϩ excretion (Na U ), red blood cell Na ϩ content (Na RBC ), Na ϩ /Ca ϩϩ ATPases activity, and Na ϩ -Li ϩ countertransport rate (Na-Li CT). The results indicate that a G-to-T substitution at nucleotide 614 in exon 10 of ␣-adducin gene which resulted in a Gly160Trp variant at amino acid 160 was found in the Han's Chinese, but lack of linkage with the HBP and of association with the Na U , Na RBC , Na ϩ /Ca ϩϩ ATPase and Na ϩ -Li ϩ CT. In conclution: a G-to-T substitution at nucleotide 614 in exon 10 of ␣-adducin gene is found in Chinese Han's population, but lack of any association with salt-sensitive hypertension and their sodium metabolism. Hypertension, left ventricular hypertrophy (LVH) and angiotensin-converting enzyme homozygous deletional (DD) genotype are all cardiovascular risk factors which, if present together, may confer especially high risk. We and others previously reported a decrease with age in the prevalence of the DD genotype in hypertensive patients, which may be due to decreased survival. In this study, we hypothesise that there might be fewer patients with the DD genotype among patients with hypertensive LVH. 70 hypertensive patients and 102 normal healthy controls were studied. LVH was determined by echocardiography in hypertensive patients. DNA was extracted from leucocytes and amplified by PCR using specific primers. Insertion (I) or deletion (D) alleles were identified after electrophoresis of PCR products. The left ventricular mass index (LVMI) in hypertensive patients with DD, ID and II genotypes were (mean Ϯ SE) 111 Ϯ 6, 115 Ϯ 5 and 136 Ϯ 8 g/m 2 respectively (p ϭ 0.03).
Hypertension, left ventricular hypertrophy (LVH) and angiotensin-converting enzyme homozygous deletional (DD) genotype are all cardiovascular risk factors which, if present together, may confer especially high risk. We and others previously reported a decrease with age in the prevalence of the DD genotype in hypertensive patients, which may be due to decreased survival. In this study, we hypothesise that there might be fewer patients with the DD genotype among patients with hypertensive LVH. 70 hypertensive patients and 102 normal healthy controls were studied. LVH was determined by echocardiography in hypertensive patients. DNA was extracted from leucocytes and amplified by PCR using specific primers. Insertion (I) or deletion (D) alleles were identified after electrophoresis of PCR products. The left ventricular mass index (LVMI) in hypertensive patients with DD, ID and II genotypes were (mean Ϯ SE) 111 Ϯ 6, 115 Ϯ 5 and 136 Ϯ 8 g/m 2 respectively (p ϭ 0.03).
In conclusion, the lower LVMI in hypertensive DD patients and the lower prevalence of the DD genotype in hypertensive patients with LVH are consistent with increased cardiovascular mortality in patients with hypertension, LVH and DD genotype. The striking mortality reductions observed in the HOPE study may be related to the ability of ACEI to address all of these risk factors. Orthostatic dysregulation of blood pressure has been shown to be associated with increase incidence of future cardiovascular event. The genetic background of orthostatic change of blood pressure was investigated in the community dwelling healthy elderly age Ն50 in Sekizen, Japan. One hundred ninety six subjects free from the medication were enrolled in the study. After 10 minutes rest in the supine position, brachial blood pressure was measured twice to obtain the basal blood pressure. Then blood pressure was measured at 1 and 3 minutes after standing up.
Angiotensin converting enzyme (ACE) I/D, Angiotensinogen (AGT) M235T, angiotensin type 1 receptor (AT1R) A1166C, and APO E genotypes were determined for each patient. There was a significant difference in change in systolic blood pressure among APO E genotypes APOE24 ϩ E34, APOE32, and APOE33, ϩ5.1 Ϯ 15.6, Ϫ4.4 Ϯ 17.8, ϩ5.4 Ϯ 15.6 mmHg, respectively (p ϭ 0.02). However, there were no significant difference in change in systolic blood pressure among genotypes of the renin-angiotensin system. Those findings indicates that genetic background is involved in orthostatic change in systolic blood pressure. Genetic involvement in carotid atherosclerosis was investigated in 200 community-dwelling healthy subjects age Ն50 in Sekizen, Japan. Intimal-media thickness (IMT) and the presence of plaque were evaluated by high resolutional ultrasonography with 7.5 MHz probe. Gene polymorphisms of the renin-angiotensin system were determined for each subject with ACE I/D, Angiotensinogen (AGT) M235T, and Angiotensin type 1 receptor (AT1R) A1166C genotypes. APOE genotype was also determined.
In a total population, there was no genotype-specific difference in carotid atherosclerosis in any genes examined. In 
